Clinical Trial Update: Nabilone in Cannabis Users With PTSD [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating nabilone in cannabis users with post-traumatic stress disorder was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis-related Disorders
• Post-traumatic Stress Disorder

Drugs mentioned

• Nabilone (nabilone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Cannabis, Post Traumatic Stress Disorder | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-10-12